Assay Report Card

Basic Information

ID: ALA3705138

Type: Binding

Description: Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).

Organism: Homo sapiens

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
552.473.743.74
548.494.914.91
566.504.084.08
578.514.284.28
552.473.743.74
548.494.914.91
548.494.914.91
532.034.404.40
532.034.404.40
530.504.774.77
532.034.404.40
550.024.544.54
532.034.404.40
550.024.544.54
566.485.055.05
530.504.774.77
548.494.914.91
566.485.055.05
550.024.544.54
548.494.914.91
548.494.914.91
576.545.645.64
562.515.255.25
576.545.695.69
827.808.138.13
544.525.165.16
568.485.245.24
564.054.934.93
546.064.794.79
562.515.305.30
546.064.794.79
562.515.305.30
546.064.794.79
564.054.934.93
580.505.445.44
562.515.305.30
560.545.925.92
530.074.524.52
524.114.594.59
562.515.305.30
568.043.713.71